Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the unaudited consolidated ....
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech has informed BSE and NSE that its Board of Directors will meet on Friday, February 13, 2026 at the registered office in New Delhi. The main agenda is to consider and approve the unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025. The company also clarified that the insider trading window for designated persons and their immediate relatives will remain closed until Sunday, February 15, 2026. This is a routine regulatory intimation filed under SEBI Listing Regulations.
No direct impact on shareholders; investors should watch the results announcement on or after February 13, 2026 for actual performance details. The closed trading window is standard practice ahead of results.